UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The prognostic significance of sentinel node tumour burden in melanoma patients: An international, multicenter study of 1539 sentinel node-positive melanoma patients

European journal of cancer (1990), 2014-01, Vol.50 (1), p.111-120

2014

Volltextzugriff (PDF)

Ultrasound-guided fine needle aspiration cytology as an addendum to sentinel lymph node biopsy can perfect the staging strategy in melanoma patients

European journal of cancer (1990), 2014-09, Vol.50 (13), p.2280-2288

2014

Volltextzugriff (PDF)

Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival

European journal of cancer (1990), 2016-11, Vol.67, p.164-173

2016

Volltextzugriff (PDF)

Melanoma

The Lancet (British edition), 2018-09, Vol.392 (10151), p.971-984

2018

Volltextzugriff (PDF)

EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria

European journal of cancer (1990), 2010-09, Vol.46 (13), p.2414-2421

2010

Volltextzugriff (PDF)

Expert opinion in melanoma: The sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden

European journal of cancer (1990), 2009-11, Vol.45 (16), p.2736-2742

2009

Volltextzugriff (PDF)

Conditional survival of malignant melanoma in The Netherlands: 1994–2008

European journal of cancer (1990), 2014-02, Vol.50 (3), p.602-610

2014

Volltextzugriff (PDF)

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma

Cell, 2019-02, Vol.176 (4), p.775-789.e18

2019

Volltextzugriff (PDF)

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022

European journal of cancer (1990), 2022-07, Vol.170, p.256-284

2022

Volltextzugriff (PDF)

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022

European journal of cancer (1990), 2022-07, Vol.170, p.236-255

2022

Volltextzugriff (PDF)

Neo-adjuvant immunotherapy emerges as best medical practice, and will be the new standard of care for macroscopic stage III melanoma

European journal of cancer (1990), 2023-03, Vol.182, p.38-42

2023

Volltextzugriff (PDF)

Increased sampling will lead to an increase in detection, but is it clinically relevant?

European journal of cancer (1990), 2012-10, Vol.48 (15), p.2488-2489

2012

Volltextzugriff (PDF)

Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma

European journal of cancer (1990), 2023-03, Vol.182, p.163-169

2023

Volltextzugriff (PDF)

Unusual first presentation of metastatic pancreatic cancer as skin metastases in a burn patient

Burns, 2010-09, Vol.36 (6), p.e111-e114

2010

Volltextzugriff (PDF)

Risk stratification of sentinel node–positive melanoma patients defines surgical management and adjuvant therapy treatment considerations

European journal of cancer (1990), 2018-06, Vol.96, p.25-33

2018

Volltextzugriff (PDF)

An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma

European journal of cancer (1990), 2019-06, Vol.114, p.1-7

2019

Volltextzugriff (PDF)

The end of wide local excision (WLE) margins for melanoma ?

European journal of cancer (1990), 2023-01, Vol.178, p.82-87

2023

Volltextzugriff (PDF)

Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003–2018): A nationwide population-based study

European journal of cancer (1990), 2021-09, Vol.154, p.111-119

2021

Volltextzugriff (PDF)

Adjuvant therapy for stage II melanoma: the need for further studies

European journal of cancer (1990), 2023-08, Vol.189, p.112914-112914, Article 112914

2023

Volltextzugriff (PDF)

Surgical outcomes of lymph node dissections for stage III melanoma after neoadjuvant systemic therapy are not inferior to upfront surgery

European journal of cancer (1990), 2023-05, Vol.185, p.131-138

2023

Volltextzugriff (PDF)

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III

European journal of cancer (1990), 2018-03, Vol.91, p.168-170

2018

Volltextzugriff (PDF)

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

European journal of cancer (1990), 2023-08, Vol.189, p.112900-112900, Article 112900

2023

Volltextzugriff (PDF)

Treatment and survival of Merkel cell carcinoma since 1993: A population-based cohort study in The Netherlands

Journal of the American Academy of Dermatology, 2019-10, Vol.81 (4), p.977-983

2019

Volltextzugriff (PDF)

1 – 25 von 38

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(38)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(38)

Sprache

Englisch
(38)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(33)
Science & Technology
(33)
Oncology
(29)
Humans
(28)
Melanoma
(28)
Melanoma - Pathology
(16)
Skin Neoplasms - Pathology
(15)
Immunotherapy
(14)
Melanoma, Cutaneous Malignant
(12)
Tumors
(12)
Male
(11)
Neoplasm Staging
(11)
Prognosis
(11)
Female
(9)
Lymph Nodes
(9)
Survival
(9)
Hematology, Oncology And Palliative Medicine
(8)
Melanoma - Drug Therapy
(8)
Melanoma - Surgery
(8)
Middle Aged
(8)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The prognostic significance of sentinel node tumour burden in melanoma patients: An international, multicenter study of 1539 sentinel node-positive melanoma patients

Ultrasound-guided fine needle aspiration cytology as an addendum to sentinel lymph node biopsy can perfect the staging strategy in melanoma patients

Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival

Melanoma

EORTC Melanoma Group sentinel node protocol identifies high rate of submicrometastases according to Rotterdam Criteria

Expert opinion in melanoma: The sentinel node; EORTC Melanoma Group recommendations on practical methodology of the measurement of the microanatomic location of metastases and metastatic tumour burden

Conditional survival of malignant melanoma in The Netherlands: 1994–2008

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma

European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022

European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022

Neo-adjuvant immunotherapy emerges as best medical practice, and will be the new standard of care for macroscopic stage III melanoma

Increased sampling will lead to an increase in detection, but is it clinically relevant?

Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022

Alternatives and reduced need for sentinel lymph node biopsy (SLNB) staging for melanoma

Unusual first presentation of metastatic pancreatic cancer as skin metastases in a burn patient

Risk stratification of sentinel node–positive melanoma patients defines surgical management and adjuvant therapy treatment considerations

An updated European Organisation for Research and Treatment of Cancer (EORTC) protocol for pathological evaluation of sentinel lymph nodes for melanoma

The end of wide local excision (WLE) margins for melanoma ?

Stage-specific trends in incidence and survival of cutaneous melanoma in the Netherlands (2003–2018): A nationwide population-based study

Adjuvant therapy for stage II melanoma: the need for further studies

Surgical outcomes of lymph node dissections for stage III melanoma after neoadjuvant systemic therapy are not inferior to upfront surgery

Prognostic and predictive value of β-blockers in the EORTC 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

Eighth American Joint Committee on Cancer (AJCC) melanoma classification: Let us reconsider stage III

Prognostic and predictive value of metformin in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma

Treatment and survival of Merkel cell carcinoma since 1993: A population-based cohort study in The Netherlands

Aktive Filter

Suchergebnisse filtern